OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer

NCT00382811 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

Fallopian Tube Cancer
Peritoneal Neoplasms
Ovarian Cancer

Interventions

DRUG: phenoxodiol
DRUG: carboplatin
DRUG: placebo

Sponsor

MEI Pharma, Inc.